{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-21-000144","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.431548+00:00","generated_at":"2026-06-28T15:11:56.687362+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgery Partners Q3 revenue up 12.7% to $559.2M; raises FY EBITDA guidance to $325-330M","bullets":["Revenue $559.2M (+12.7% YoY); net loss $22.9M; adjusted EBITDA $76.4M (+25% YoY).","Same-facility revenue +8.3%, case volume +6.2% vs prior year quarter.","FY 2021 adjusted EBITDA guidance raised to $325M-$330M.","Deployed over $130M on acquisitions YTD; 3 ASCs bought in Aug; $225M under LOI.","Cash $330.4M; revolver capacity $163M; net debt/EBITDA ratio 6.25x."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-21-000144","json":"https://secwatch.observer/filing/0001638833-21-000144.json","markdown":"https://secwatch.observer/filing/0001638833-21-000144.md","text":"https://secwatch.observer/filing/0001638833-21-000144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/0001638833-21-000144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/sgry-20211102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:11:56.687362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}